A new FDA program seeks to enlist healthcare professionals in flagging improper sales tactics for prescription drugs.Here is the FDA letter.
Although the agency calls the program "Bad Ad," its interest goes beyond broadcast and print advertisements to include misleading in-person presentations.
Bad drug ads are bad, but they do not harm as many people IMHO as AdipOprah and her experts. (e.g., see here, here, here and here)
No comments:
Post a Comment